DETECTION OF REPERFUSED ISCHEMIA OF THE RAT INTESTINE - VALUE OF MAGNETIC-RESONANCE-IMAGING WITH SMALL-MOLECULAR-WEIGHT DYSPROSIUM AND GADOLINIUM CHELATES
Be. Vanbeers et al., DETECTION OF REPERFUSED ISCHEMIA OF THE RAT INTESTINE - VALUE OF MAGNETIC-RESONANCE-IMAGING WITH SMALL-MOLECULAR-WEIGHT DYSPROSIUM AND GADOLINIUM CHELATES, Academic radiology, 4(1), 1997, pp. 35-42
Rationale and Objectives. The authors assessed whether the small-molec
ular-weight magnetic resonance (MR) imaging contrast agents dysprosium
diethylenetriamepentaacetic acid bismethylamide (sprodiamide injectio
n), which enhances T2, and gadolinium diethylenetriamepentaacetic aci
d bismethylamide (gadodiamide injection), which enhances T1, could imp
rove the detection of reperfused ischemia of the rat intestine, Method
s. Eighteen rats were subjected to vascular occlusion of the distal il
eum for 30 minutes, followed by reperfusion. Ten minutes after reperfu
sion, T1- and T2-weighted spin-echo (SE) images were obtained before a
nd after administration of sprodiamide, gadodiamide, or both, The same
imaging protocol was applied in another group of 18 rats subjected to
10 minutes of occlusion and reperfusion. Histologic examination of th
e intestine was performed after MR imaging, Results. Villous injury (i
e, denudation) was observed in most cases after 30 minutes of occlusio
n, but not after 10 minutes of occlusion. After 30 minutes of occlusio
n, the superficial part of the ischemic intestine was hyperintense to
the normal intestine on unenhanced T2-weighted images. Administration
of sprodiamide improved the contrast between the normal and ischemic i
ntestine on T2-weighted images, and administration of both gadodiamide
and sprodiamide improved the contrast on T1- and T2-weighted images.
After 10 minutes of occlusion, no contrast was discernible before or a
fter contrast material administration.Conclusion. These results sugges
t that the detection of reperfused intestinal ischemia of sufficient d
uration to cause villous injury can be improved by using sprodiamide i
njection alone or in combination with gadodiamide.